Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.260
+0.060 (5.00%)
At close: Jul 3, 2025, 1:00 PM
1.280
+0.020 (1.59%)
After-hours: Jul 3, 2025, 4:36 PM EDT
Pliant Therapeutics Employees
Pliant Therapeutics had 171 employees as of December 31, 2024. The number of employees increased by 13 or 8.23% compared to the previous year.
Employees
171
Change (1Y)
13
Growth (1Y)
8.23%
Revenue / Employee
n/a
Profits / Employee
-$1,283,713
Market Cap
77.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PLRX News
- 9 days ago - Pliant Therapeutics Provides Update on BEACON-IPF - GlobeNewsWire
- 6 weeks ago - Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations - GlobeNewsWire
- 3 months ago - Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference - GlobeNewsWire
- 3 months ago - Pliant Therapeutics: An Activist On Deck - Seeking Alpha
- 3 months ago - Pliant Therapeutics Announces Interim Phase 1 Data for PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - GlobeNewsWire
- 4 months ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PRNewsWire